Unilateral gene therapy surprisingly improves visions in both eyes

Date: 14th December 2020

Leber hereditary optic neuropathy (LHON) is the most common inherited mitochondrial disorder affecting around 1 in 30,000 to 50,000 people. It is characterised by selective loss of retinal ganglion cells (RGCs) and their axons, which causes optic nerve degeneration and can lead to vision loss in just a few weeks after disease onset. Now, scientists have reported they have successfully administered gene therapy to 37 patients to correct LHON in a Phase 3 trial. Surprisingly 78% experienced a significant visual improvement in both eyes, even though only one eye had been treated.

Three mitochondria DNA (mtDNA) point mutations account for about 90% of all LHON cases, and affect the complex I subunits of the mitochondrial respiratory chain, impairing mitochondrial function and increasing the production of reactive oxygen species. Whilst, LHON is amenable to gene therapy as it has well-defined onset and progression, and RGCs are easily accessible, it is challenging as mitochondria disorders add a layer of complexity as the wild type therapy protein has to reach the mitochondrial compartment.

Now a team of scientists led by Patrick Yu-Wai-Man from the University of Cambridge, UK, and José-Alain Sahel from the University of Pittsburgh, US, and the Institut de la Vision, France, have used a recombinant replication-defective adeno-associated virus, AAV, to deliver a modified complementary DNA encoding NADH-ubiquinone oxidoreductase chain 4 (ND4) into one eye of LHON patients. The team unexpectedly found significant vision improvement in both eyes, and showed in non-human primates this may be due to viral vector DNA transfer between the eyes.

The team enrolled 37 subjects with LHON due to one specific mutation (m.11778G>A) who had experienced vision loss between 6 to 12 months. The participants were injected into the vitreous humour of one eye with an AAV carrying DNA encoding the human wild-type mitochondrial ND4 protein. This also contained a specific mitochondrial targeting sequence (MTS) that allowed translocation of the protein in to the mitochondrial matrix. The unilateral treatment-injection was performed under the assumption that the therapeutic effects of treated versus untreated/sham injected eyes would be compared.

The participants were examined after 96 weeks and whilst the team found a clinically relevant response was higher in the treated eyes (62%) compared with the sham eye group (42%) they were surprised to find around 78% of participants had increased vision in both eyes. To put this in perspective this accounted for a mean improvement in best-corrected visual acuity (BCVA) of 15 letters on an ETDRS chart (a standard test) for the treated eyes - representing three lines of vision, while a mean improvement of 13 letters was observed in the sham treated eyes.

Intrigued by increased vision in both eyes, the team went on to investigate this further in a non-human primate model, cynomolgus macaques, as this species has a similar vision system to us. Here, they found that there was evidence of transfer of viral vector DNA from the injected eye to the anterior segment, retina, and optic nerve of the contralateral non-injected eye providing a mechanistic explanation for vision improvement in both eyes.

Conclusion and future applications

The team here have shown bilateral improvement of visual function in LHON subjects treated with a unilateral intravitreal injection with ND4-AAV, likely due to viral DNA transfer between the eyes. Although this underlying transfer needs further investigation, it could have profound implications for gene therapy clinical trial design and outcome measures.

The team hope this method of preserving RGC function and improving the patient’s visual prognosis will be life-changing for patients and that sight-saving gene therapy is now a reality. The treatment has been shown to be safe and the team are now exploring the optimal therapeutic window.

This work adds to the flurry of recent gene therapies designed to restore vision. From reprogramming retina cells, to restore youthful DNA methylation patterns, which promoted axon regeneration - to gene therapy to deliver an adapter molecule, Protrudin, into the eye which stimulated axon regeneration of the damaged nerve fibres, and protected them from cell death after injury - or the delivery of a highly photosensitive multi-characteristic opsin (MCO1) protein into retina bipolar cells.

However, whilst these preclinical trials are showing promising results in mice, this Phase 3 trial in humans offers a tangible therapy that should translate into a treatment in the not so distant future, offering hope to LHON sufferers. From a wider perspective this approach could also be applied to treating other types of mitochondrial diseases.

 

For more information please see the press release from the University of Cambridge

 

Yu-Wai-Man, P., N. J. Newman, V. Carelli, M. L. Moster, V. Biousse, A. A. Sadun, T. Klopstock, C. Vignal-Clermont, R. C. Sergott, G. Rudolph, C. La Morgia, R. Karanjia, M. Taiel, L. Blouin, P. Burguière, G. Smits, C. Chevalier, H. Masonson, Y. Salermo, B. Katz, S. Picaud, D. J. Calkins and J.-A. Sahel (2020). “Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy.” Science Translational Medicine 12(573): eaaz7423.

https://doi.org/10.1126/scitranslmed.aaz7423

 

  1. https://www.gustudentassociation.org/
  2. https://kimmerestaurant.com/
  3. https://www.nyonyafood.com/
  4. https://www.perfectotech.com/
  5. https://www.planetgapyear.com/
  6. https://whatcomvet.com/
  7. https://theclassicyachtexperience.com/
  8. https://www.batonrougerosesociety.org/
  9. https://www.finburysullivan.com/
  10. https://mikrofinanzinstitut.com/
  11. https://www.the-vision-of-harmony.org/
  12. https://www.pantheonpress.com/
  13. https://thefinancialgraduate.com/
  14. https://www.thenutkitchen.com/
  15. https://altiboutique.com/
  16. https://ambushsweden.com/
  17. https://goingonforgod.com/
  18. https://lasdopestattorney.com/
  19. https://www.sewardne.com/
  20. https://www.tehranfestival.com/
  21. https://brysonchristianmontessorischool.com/
  22. https://www.excalibureurope.com/
  23. https://www.originallotsoflox.com/
  24. https://www.wavespace-berlin.com/
  25. https://www.michiganmediates.org/
  26. https://www.yourmyrtlebeachproperty.com/
  27. https://metrcconference.com/
  28. https://biotechscope.com/
  29. https://jzbrasil.com/
  30. https://saafootball.org/
  31. https://griefergames.info/
  32. https://ampalauragarcianoblejas.com/
  33. sbobet
  34. judi parlay
  35. togel kamboja
  36. Pengeluaran Cambodia
  37. judi bola
  38. Togel Kamboja
  39. keluaran Kamboja
  40. slot thailand
  41. togel kamboja
  42. keluaran kamboja
  43. togel Kamboja
  44. slot demo
  45. keluaran cambodia
  46. togel cambodia
  47. live draw macau
  48. slot thailand
  49. pengeluaran kamboja
  50. judi bola
  51. sbobet
  52. slot demo
  53. togel sdy
  54. demo slot
  55. keluaran kamboja
  56. judi sbobet
  57. slot qris
  58. slot qris 5000
  59. slot qris
  60. slot deposit 5000
  61. slot qris
  62. pintarbersamamedan.org
  63. slot qris gacor
  64. slot qris 5000
  65. toto macau
  66. pengeluaran macau
  67. macau pools
  68. slot server thailand super gacor
  69. slot qris 5k
  70. toto hk
  71. toto sdy
  72. toto sgp
  73. togel hk
  74. togel hk
  75. togel hk
  76. togel hk
  77. data hk
  78. data sdy
  79. togel
  80. data sdy
  81. generasitogel
  82. generasitogel
  83. generasitogel
  84. Live Draw HK
  85. HK Lotto
  86. Live SDY Lotto
  87. Live HK
  88. Live Draw SDY
  89. Live SDY Lotto
  90. situs slot dana
  91. TOGEL SDY
  92. Slot Qris Dana
  93. Live Toto Macau
  94. KELUARAN HK
  95. generasitogel
  96. Live Draw HK
  97. Live Draw Singapore
  98. Live HK
  99. pengeluaran macau
  100. Live Draw HK
  101. Live Togel Singapore
  102. Live Draw SDY
  103. Data HK
  104. Live Draw SDY
  105. Live Draw SGP
  106. Togel SDY
  107. Togel HK
  108. Live Togel SGP